Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Is there a bad time for intravenous thrombolysis? The experience of Polish stroke centers.

Karliński M, Kobayashi A, Sobolewski P, Lisewski P, Romanowicz S, Fryze W, Nyka W, Zięba M, Dorobek M, Członkowska A.

Neurol Neurochir Pol. 2014 Jan-Feb;48(1):45-51. doi: 10.1016/j.pjnns.2013.12.003. Epub 2014 Jan 23.

PMID:
24636770
2.

Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland.

Karliński M, Kobayashi A, Litwin T, Sobolewski P, Fryze W, Romanowicz S, Glonek M, Nyka W, Lisewski P, Członkowska A; SITS Poland Collaborative Group.

Neurol Neurochir Pol. 2012 Jan-Feb;46(1):3-14.

PMID:
22426757
3.

Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.

Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1175-83. doi: 10.1016/j.jstrokecerebrovasdis.2013.02.010. Epub 2013 Mar 16.

PMID:
23507462
4.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

5.

Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.

Dorado L, Ahmed N, Thomalla G, Lozano M, Malojcic B, Wani M, Millán M, Tomek A, Dávalos A.

Stroke. 2017 Mar;48(3):720-725. doi: 10.1161/STROKEAHA.116.014889. Epub 2017 Feb 7.

6.

Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?

Fang K, Churilov L, Weir L, Dong Q, Davis S, Yan B.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):427-32. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.029. Epub 2013 Apr 28.

PMID:
23635920
8.

Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.

Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N; SITS investigators.

Neurology. 2012 Mar 20;78(12):880-7. doi: 10.1212/WNL.0b013e31824d966b. Epub 2012 Mar 7.

PMID:
22402853
9.

Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.

Kim DH, Cha JK, Park HS, Choi JH, Kang MJ, Huh JT.

J Clin Neurosci. 2014 Aug;21(8):1428-32. doi: 10.1016/j.jocn.2014.03.014. Epub 2014 Jun 26.

PMID:
24980628
10.

Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.

Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Okuda S, Yamagami H, Okada Y, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1098-106. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.013. Epub 2012 Oct 10.

PMID:
23063059
11.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
12.

Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR.

Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, Parsons M, Roine RO, Toni D, Ringleb P; SITS investigators.

Lancet Neurol. 2010 Sep;9(9):866-74. doi: 10.1016/S1474-4422(10)70165-4. Epub 2010 Jul 26.

PMID:
20667790
13.

Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.

Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.

Cerebrovasc Dis. 2012;34(2):140-6. doi: 10.1159/000339759. Epub 2012 Aug 1.

PMID:
22854333
14.

Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.

Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.

Neurosurgery. 2009 Nov;65(5):860-5; discussion 865. doi: 10.1227/01.NEU.0000358953.19069.E5.

PMID:
19834397
15.

Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.

Qureshi AI, Miley JT, Chaudhry SA, Semaan E, Rodriguez GJ, Suri MF, Adams HP Jr.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1076-81. doi: 10.1016/j.jstrokecerebrovasdis.2012.07.015. Epub 2012 Oct 23.

PMID:
23099041
16.

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).

Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T; J-MARS Investigators.

Stroke. 2010 Sep;41(9):1984-9. doi: 10.1161/STROKEAHA.110.589606. Epub 2010 Jul 22.

17.

Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.

Deguchi I, Dembo T, Yoshimura S, Sakai N, Okada Y, Kitagawa K, Kimura K, Hyogo T, Yamagami H, Egashira Y, Tanahashi N.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1471-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.053. Epub 2014 Mar 28.

PMID:
24685994
18.

Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.

Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.

Cerebrovasc Dis. 2013;35(5):461-8. doi: 10.1159/000350201. Epub 2013 May 31.

PMID:
23735898
19.

Intravenous tissue plasminogen activator for patients with minor ischemic stroke.

Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):732-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.03.009. Epub 2011 Apr 30.

20.

Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.

Tsivgoulis G, Sharma VK, Mikulik R, Krogias C, Haršány M, Bavarsad Shahripour R, Athanasiadis D, Teoh HL, Piperidou C, Alexandrov AV.

Int J Stroke. 2014 Jun;9(4):413-8. doi: 10.1111/ijs.12125. Epub 2013 Aug 26.

PMID:
23981541

Supplemental Content

Support Center